1 | 10% intravenous immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬
|
2 | 10% liquid formulation of human immunoglobulin | - | - | - | - | [1] 14 14 💬
|
3 | : immunoglobulina umana normale 10% per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬
|
4 | Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain) | - | - | - | - | [1] 271 271 💬
|
5 | Anti-human immunoglobulin, equine | - | - | - | - | [1] 60 60 💬
|
6 | Anti-human T-lymphocyte immunoglobulin from horse | - | - | - | - | [1] 60 60 💬
|
7 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | [1] 51 51 💬
|
8 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2] 96 96, 97 💬
|
9 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 💬
|
10 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 💬
|
11 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | [1] 96 96 💬
|
12 | ANTITHYMOCYTE IMMUNOGLOBULIN | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [2] 13 13, 96 💬
|
13 | Antithymocyte immunoglobulin (rabbit) | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2] 13 13, 96 💬
|
14 | Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬
|
15 | Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬
|
16 | Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 💬
|
17 | Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 💬
|
18 | Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 43, 45 💬
|
19 | Gammaplex (Intravenous immunoglobulin) | - | - | - | - | [1] 65 65 💬
|
20 | Gammaplex, intravenous immunoglobulin | - | - | - | - | [1] 63 63 💬
|
21 | GB-0998 (Intravenous immunoglobulin) | - | - | - | - | [1] 11 11 💬
|
22 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | [1] 18 18 💬
|
23 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | [1] 51 51 💬
|
24 | Human Immunoglobulin | - | - | - | - | [2] 63 63, 65 💬
|
25 | HUMAN IMMUNOGLOBULIN G | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 50, 63, 65 💬
|
26 | Human normal 10% immunoglobulin for intravenous administration | - | - | - | - | [1] 14 14 💬
|
27 | Human normal 10% immunoglobulin for intravenous administrationn | - | - | - | - | [1] 14 14 💬
|
28 | Human normal immunoglobulin | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [9] 11 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
|
29 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 63, 65 💬
|
30 | Human normal immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 50, 65 💬
|
31 | Human normal immunoglobulin (SCIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬
|
32 | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬
|
33 | Human normal immunoglobulin (subcutaneous) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬
|
34 | HUMAN NORMAL IMMUNOGLOBULIN FOR | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬
|
35 | Human normal immunoglobulin for intravenous (IV) administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 51 51 💬
|
36 | Human normal immunoglobulin for intravenous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 51, 65 💬
|
37 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 63 63, 65 💬
|
38 | Human normal immunoglobulin for intravenous use (IVIG) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬
|
39 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 63 63 💬
|
40 | Human normal immunoglobulin for subcutaneous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 51 51, 65 💬
|
41 | Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬
|
42 | Human normal immunoglobulin G (IgG > 98% purity) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 63, 65 💬
|
43 | Human normal immunoglobulin G (IgG) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 💬
|
44 | Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody | - | - | - | - | [1] 46 46 💬
|
45 | I.v. immunoglobulins | - | - | - | - | [1] 151 151 💬
|
46 | Immunoglobulin | - | - | - | - | [3] 13 13, 14, 63 💬
|
47 | Immunoglobulin (Hizentra) | - | - | - | - | [1] 50 50 💬
|
48 | IMMUNOGLOBULIN G | - | - | - | - | [8] 2 2, 11, 13, 14, 49, 50, 63, 65 💬
|
49 | Immunoglobulin G (Ig NextGen 16%) | - | - | - | - | [1] 65 65 💬
|
50 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy | - | - | - | - | [1] 2 2 💬
|
51 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer | - | - | - | - | [1] 2 2 💬
|
52 | Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer | - | - | - | - | [1] 49 49 💬
|
53 | Immunoglobulin intravenous (human) | - | - | - | - | [1] 65 65 💬
|
54 | Immunoglobulin perfusion | - | - | - | - | [1] 14 14 💬
|
55 | Immunoglobulina normale umana | - | - | - | - | [1] 51 51 💬
|
56 | Immunoglobulina Normale Umana per somministrazione endovenosa | - | - | - | - | [1] 51 51 💬
|
57 | Immunoglobulina Normale Umana per somministrazione sottocutanea | - | - | - | - | [1] 51 51 💬
|
58 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [2] 51 51, 65 💬
|
59 | IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬
|
60 | Immunoglobuline G | - | - | - | - | [1] 14 14 💬
|
61 | Immunoglobulins | - | - | - | - | [1] 14 14 💬
|
62 | Immunoglobulins Intravenous (Human) | - | - | - | - | [1] 65 65 💬
|
63 | Immunoglobulins, normal human | - | - | - | - | [1] 65 65 💬
|
64 | Immunoglobulins, normal human, for extravascular adm. | - | - | - | - | [1] 14 14 💬
|
65 | Immunoglobulins, normal human, for intravascular adm. | - | - | - | - | [2] 14 14, 15 💬
|
66 | Intravenous Immunoglobulin | - | - | - | - | [7] 13 13, 14, 35, 38, 39, 51, 309 💬
|
67 | Intravenous immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 17, 164, 296 💬
|
68 | Intravenous immunoglobulin (IVIG), 10% solution for infusion | - | - | - | - | [1] 63 63 💬
|
69 | Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
70 | Intravenous immunoglobulin infusion | - | - | - | - | [1] 65 65 💬
|
71 | Intravenous immunoglobulins (human immunoglobulins G) | - | - | - | - | [1] 43 43 💬
|
72 | Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬
|
73 | L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [1] 13 13 💬
|
74 | Normal human immunoglobulin G | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 💬
|
75 | Rabbit anti-human thymocyte immunoglobulin | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2] 13 13, 96 💬
|
76 | RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 60 💬
|
77 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 💬
|
78 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
79 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 💬
|
80 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 💬
|